Gabriel Tremblay is a distinguished applied economist with over 17 years of experience in health economic studies and health technology assessments. His career spans a wide array of industries within the healthcare sector, including pharmaceuticals, medical devices, and biotechnology, where he has provided groundbreaking insights into cost-effectiveness analysis, economic evaluations, and value-based reimbursement strategies. Gabriel’s dedication to improving healthcare outcomes through meticulous analysis and global collaboration sets him apart as a leader in his field.

Currently, Gabriel serves as an independent Health Economics and Comparative Effectiveness Consultant and Advisor, providing expertise in health economics, HEOR (Health Economics and Outcomes Research), and HTA (Health Technology Assessment) submissions. His advisory roles span biotech and pharmaceutical companies, where he helps secure reimbursement from public and private payers. He is also an angel investor, focusing on startups with transformative potential in healthcare technologies and therapies.

Previously, Gabriel co-founded Purple Squirrel Economics, a consulting firm specializing in reimbursement strategies and payer submissions, which he successfully sold to a venture capital fund. He continued his leadership journey as Vice President of Health Economics and Comparative Effectiveness at Cytel, where he directed global projects on payer submissions and value-based pricing. His deep understanding of economic evaluation and global reimbursement landscapes has been instrumental in shaping successful commercialization strategies for healthcare innovations.

Gabriel has authored approximately 170 peer-reviewed articles and conducted over 150 health economics and HTA analyses. His work has informed more than 130 economic submissions to payers in over 40 countries, including the US, Canada, and Western Europe. His expertise in personalized medicine, orphan drugs, and advanced modeling techniques like Bayesian analysis has positioned him as a sought-after expert in his field.

His academic journey is equally remarkable. Gabriel earned a Doctorate in Business Administration specializing in healthcare decision-making and health technology assessment from Université Jean Moulin (Lyon III) and the Business Science Institute. He also holds an MSc in Applied Health Economics from HEC Montréal and a BA in Economics from Université Laval. His rigorous academic training underscores his analytical rigor and strategic thinking.

Gabriel’s commitment to healthcare innovation extends beyond consulting. As an angel investor and board member, he collaborates with companies to identify their economic value and helps them navigate the complexities of commercialization. His contributions to advisory boards in biotech, pharma, and medical devices are marked by his ability to combine technical expertise with actionable business insights.

In addition to his professional accomplishments, Gabriel is passionate about spending time outdoors with his three children. He values family and personal growth, which fuels his dedication to fostering innovation in healthcare. He believes that by aligning economic strategies with patient-centered outcomes, the healthcare industry can achieve sustainable growth and greater accessibility.

Gabriel’s international exposure is extensive, having worked on reimbursement and submission projects in 40+ countries. His ability to bridge regional payer requirements with global market needs makes him a valuable partner for companies aiming to succeed in the healthcare sector. Fluent in both English and French, he is adept at fostering cross-cultural collaboration.

Characterized by his integrity, Gabriel leads with a commitment to empowering others, fostering partnerships, and driving impactful outcomes. His exceptional communication skills, combined with his strategic vision, enable him to navigate complex challenges and deliver innovative solutions. Gabriel’s career exemplifies his belief that sound economic strategies can transform healthcare delivery and improve lives.

Character:

Gabriel Tremblay is driven by a strong sense of integrity and a commitment to innovation, consistently prioritizing meaningful contributions to healthcare economics. His resilience and dedication to fostering collaboration define his approach to leadership and problem-solving.

Knowledge:

With a foundation of advanced academic training and extensive practical experience, Gabriel blends deep expertise in health economics with real-world application. His comprehensive understanding of global reimbursement strategies positions him as a leader in healthcare innovation.

Strategic:

Gabriel excels at aligning economic evaluations with business objectives, enabling successful commercialization of healthcare technologies. His ability to anticipate industry trends and craft actionable strategies makes him an invaluable partner to organizations navigating complex markets.

Communication:

As a fluent communicator in English and French, Gabriel bridges cultural and technical divides to facilitate effective collaboration. His talent for simplifying complex concepts empowers stakeholders to make informed, impactful decisions.